Abstract 644: Validation of PD-L1 staining by IHC in solid tumors: A journey from xenograft model to ex vivo culture of clinical samplesXiaoqian Lin(Avera Health), Brian Leyland‐Jones(Avera Health)Cancer ResearchJuly 1, 201810.1158/1538-7445.am2018-644Cited by 0SaveCiteExport RISWatch citationsRelated PapersAbstract 4579: A comparative immune-landscape within tumor-microenvironment: Pattern of distribution of immune cells in tumor versus tumor-adjacent normal tissues|Cancer Research|2019|0Abstract 4579: A comparative immune-landscape within tumor-microenvironment: Pattern of distribution of immune cells in tumor versus tumor-adjacent normal tissues|Tumor Biology|2019|0